These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25457185)

  • 21. Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue.
    Reid-Nicholson MD; Motiwala N; Drury SC; Peiper SC; Terris MK; Waller JL; Ramalingam P
    Ann Diagn Pathol; 2011 Feb; 15(1):37-45. PubMed ID: 21238914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas.
    Herbers J; Schullerus D; Chudek J; Bugert P; Kanamaru H; Zeisler J; Ljungberg B; Akhtar M; Kovacs G
    J Pathol; 1998 Jan; 184(1):58-62. PubMed ID: 9582528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma.
    Cheng L; MacLennan GT; Zhang S; Wang M; Zhou M; Tan PH; Foster S; Lopez-Beltran A; Montironi R
    Clin Cancer Res; 2008 Dec; 14(24):8087-93. PubMed ID: 19088024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics.
    Siebert R; Jacobi C; Matthiesen P; Zühlke-Jenisch R; Potratz C; Zhang Y; Stöckle M; Klöppel G; Grote W; Schlegelberger B
    J Urol; 1998 Aug; 160(2):534-9. PubMed ID: 9679924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular classification of adult renal epithelial neoplasms using microRNA expression and virtual karyotyping.
    Powers MP; Alvarez K; Kim HJ; Monzon FA
    Diagn Mol Pathol; 2011 Jun; 20(2):63-70. PubMed ID: 21532496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of chromosomal aberrations in renal tumors: a comparative study of conventional cytogenetics and virtual karyotyping with single-nucleotide polymorphism microarrays.
    Monzon FA; Alvarez K; Gatalica Z; Bridge JA; Nelson M; Kim HJ; Hagenkord JM
    Arch Pathol Lab Med; 2009 Dec; 133(12):1917-22. PubMed ID: 19961245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
    Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
    Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of tissue microarrays for assessment of chromosomal abnormalities in chromophobe renal cell carcinoma.
    Brunelli M; Delahunt B; Ficarra V; Gobbo S; Eccher A; Cossu-Rocca P; Zattoni F; Cheng L; Eble JN; Martignoni G
    Anal Quant Cytol Histol; 2009 Dec; 31(6):401-9. PubMed ID: 20698356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
    Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EGF-r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization.
    Moch H; Sauter G; Gasser TC; Bubendorf L; Richter J; Presti JC; Waldman FM; Mihatsch MJ
    J Pathol; 1998 Apr; 184(4):424-9. PubMed ID: 9664910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for routine clinical use on formalin-fixed paraffin-embedded tissues.
    Lyons-Weiler M; Hagenkord J; Sciulli C; Dhir R; Monzon FA
    Diagn Mol Pathol; 2008 Mar; 17(1):3-13. PubMed ID: 18303412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic alterations in renal cell carcinoma with rhabdoid differentiation.
    Perrino CM; Hucthagowder V; Evenson M; Kulkarni S; Humphrey PA
    Hum Pathol; 2015 Jan; 46(1):9-16. PubMed ID: 25439741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma.
    Strefford JC; Stasevich I; Lane TM; Lu YJ; Oliver T; Young BD
    Cancer Genet Cytogenet; 2005 May; 159(1):1-9. PubMed ID: 15860350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas.
    Schullerus D; Herbers J; Chudek J; Kanamaru H; Kovacs G
    J Pathol; 1997 Oct; 183(2):151-5. PubMed ID: 9390026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis.
    Gobbo S; Eble JN; Maclennan GT; Grignon DJ; Shah RB; Zhang S; Martignoni G; Brunelli M; Cheng L
    Am J Surg Pathol; 2008 Dec; 32(12):1780-6. PubMed ID: 18779729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma.
    Varella-Garcia M; Gemmill RM; Rabenhorst SH; Lotto A; Drabkin HA; Archer PA; Franklin WA
    Cancer Res; 1998 Oct; 58(20):4701-7. PubMed ID: 9788625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study.
    Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
    Mod Pathol; 2003 Oct; 16(10):1053-9. PubMed ID: 14559990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma.
    Jahromi MS; Putnam AR; Druzgal C; Wright J; Spraker-Perlman H; Kinsey M; Zhou H; Boucher KM; Randall RL; Jones KB; Lucas D; Rosenberg A; Thomas D; Lessnick SL; Schiffman JD
    Cancer Genet; 2012; 205(7-8):391-404. PubMed ID: 22868000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter, cross-platform clinical validation study of cancer cytogenomic arrays.
    Li MM; Monzon FA; Biegel JA; Jobanputra V; Laffin JJ; Levy B; Leon A; Miron P; Rossi MR; Toruner G; Alvarez K; Doho G; Dougherty MJ; Hu X; Kash S; Streck D; Znoyko I; Hagenkord JM; Wolff DJ
    Cancer Genet; 2015 Nov; 208(11):525-36. PubMed ID: 26454669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
    Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
    Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.